Belvedere Trading LLC Tyra Biosciences, Inc. Transaction History
Belvedere Trading LLC
- $82.2 Billion
- Q4 2024
A detailed history of Belvedere Trading LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Belvedere Trading LLC holds 14,400 shares of TYRA stock, worth $174,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,400Holding current value
$174,960% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TYRA
# of Institutions
105Shares Held
47.3MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$127 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$78.3 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$56.6 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.18MShares$50.8 Million97.27% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$49.6 Million89.47% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $510M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...